Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Moat Score: 0/10 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920344 Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
77 GF Score
Price ¥18.55
GF Value ¥25.94
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Beijing Tri Prime Gene Pharmaceutical Co Moat Score?

Beijing Tri Prime Gene Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Beijing Tri Prime Gene Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Beijing Tri Prime Gene Pharmaceutical Co might have No Moat - No discernible moat.

Beijing Tri Prime Gene Pharmaceutical Co  (BJSE:920344) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Beijing Tri Prime Gene Pharmaceutical Co Moat Score Related Terms

BJSE:920344
77GF Score
Beijing Tri Prime Gene Pharmaceutical Co Ltd BJSE:920344
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥18.55 is trading 28.5% below its estimated GF Value™ of ¥25.94. GuruFocus considers Beijing Tri Prime Gene Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920344:

  • Moat Score: 0
  • GF Value™: ¥25.94 vs. price of ¥18.55 (28.5% below fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920344 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tri Prime Gene Pharmaceutical Co Business Description

Address No. 20, Jinghong Street, Biomedicine Base, Daxing District, Beijing, CHN, 102600
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products, including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and is engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, and Yundexol Water Injection.
77GF Score

Get the complete analysis for BJSE:920344

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.55
Price
¥25.94
GF Value